Meridian™
Universe

DMRA · CIK 0001800315 · FY2025 live · 2025-12-31

Damora Therapeutics, Inc.

GreySEC 10-KClassic ZHealthcare84th percentile in Healthcare · 736 names

View as

Model

Classic Z

FY2025

2.98

Zone

Grey

Prior

—

Market DD

—

1y PD

—

2.98

Z″ 7.04

−21.83.08+

Score 2.98 · distress below 1.80, grey to 2.99, safe at 3.00 and above.

Classic Z factor contributions

  • X1 Working capital / assets

    Short-term liquidity versus the size of the balance sheet.

    0.92
    1.2 × = 1.11

  • X2 Retained earnings / assets

    Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.

    −1.87
    1.4 × = −2.62

  • X3 EBIT / assets

    Operating return on assets. Highest weight in the original model.

    −0.81
    3.3 × = −2.67

  • X4 Book equity / liabilities

    Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.

    11.93
    0.6 × = 7.16

  • X5 Sales / assets

    Asset turnover — how much revenue the asset base supports.

    0.00
    1 × = 0.00

Five-year path

Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.

Meridian Rank

58.73

0–100 · Classic Z family

  • Book standing

    80

  • Year change

    —

  • Market PD

    —

  • O-score

    2

Events on this name

Same published rows as Today.

No published events on this print.

Overview

rule-v1

Damora Therapeutics, Inc. is on classic Z at 2.98 (grey) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.

Book screen Grey; market PD —. Market PD has not been priced on this name.

Market DD · naive Merton

No market tape yet.

Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.

Sector peers

Closest Classic Z scores · 84th percentile in Healthcare.

Filing line items

Current assets

$260M

Total assets

$261M

Current liabilities

$20M

Total liabilities

$20M

Working capital

$240M

Retained earnings

−$487M

EBIT

−$211M

Total sales

$0

Book equity

$240M

Accession 0001193125-26-115922. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.